ATE348886T1 - Auf zelluläre ziele gerichtete verbindungen - Google Patents
Auf zelluläre ziele gerichtete verbindungenInfo
- Publication number
- ATE348886T1 ATE348886T1 AT01947636T AT01947636T ATE348886T1 AT E348886 T1 ATE348886 T1 AT E348886T1 AT 01947636 T AT01947636 T AT 01947636T AT 01947636 T AT01947636 T AT 01947636T AT E348886 T1 ATE348886 T1 AT E348886T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- elements
- soluble
- membrane
- cellular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Mobile Radio Communication Systems (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0016811.2A GB0016811D0 (en) | 2000-07-07 | 2000-07-07 | Lipid rafts |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE348886T1 true ATE348886T1 (de) | 2007-01-15 |
Family
ID=9895288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01947636T ATE348886T1 (de) | 2000-07-07 | 2001-07-06 | Auf zelluläre ziele gerichtete verbindungen |
Country Status (8)
Country | Link |
---|---|
US (2) | US20040043432A1 (de) |
EP (1) | EP1299537B1 (de) |
AT (1) | ATE348886T1 (de) |
AU (1) | AU2001269282A1 (de) |
CA (1) | CA2415478A1 (de) |
DE (1) | DE60125364D1 (de) |
GB (1) | GB0016811D0 (de) |
WO (1) | WO2002004638A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835545B2 (en) | 2000-05-08 | 2004-12-28 | President And Fellows Of Harvard College | Methods, products and treatments for diabetes |
US7833725B2 (en) | 2005-01-06 | 2010-11-16 | President And Fellows Of Harvard College | Mass spectrometric methods and products |
AU2015202046B2 (en) * | 2008-02-15 | 2017-06-29 | Tufts University | A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
CA2843684A1 (en) * | 2010-08-13 | 2012-02-16 | Tufts University | Compositions, kits and methods for treatment of macular degeneration using soluble membrane-independent cd59 protein |
WO2012027555A2 (en) | 2010-08-25 | 2012-03-01 | President And Fellows Of Harvard College | Glycated cd59 peptides, their preparation, and uses thereof |
WO2015017316A2 (en) | 2013-08-01 | 2015-02-05 | Abbott Nicholas L | Methods and compositions for modifying mucous membranes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0114787B1 (de) * | 1983-01-25 | 1991-09-25 | Ciba-Geigy Ag | Neue Peptidderivate |
US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
US5256642A (en) * | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
US5326700A (en) * | 1990-11-06 | 1994-07-05 | Eli Lilly And Company | DNA sequences encoding t-PA derivatives with cleavable sites |
US5856300A (en) * | 1994-05-12 | 1999-01-05 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
CA2184356A1 (en) * | 1994-03-03 | 1995-09-08 | Russell P. Rother | Terminal complement inhibitor fusion genes and proteins |
GB9614871D0 (en) * | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
US5776689A (en) * | 1996-07-19 | 1998-07-07 | The Regents Of The University Of California | Protein recruitment system |
-
2000
- 2000-07-07 GB GBGB0016811.2A patent/GB0016811D0/en not_active Ceased
-
2001
- 2001-07-06 CA CA002415478A patent/CA2415478A1/en not_active Abandoned
- 2001-07-06 EP EP01947636A patent/EP1299537B1/de not_active Expired - Lifetime
- 2001-07-06 DE DE60125364T patent/DE60125364D1/de not_active Expired - Lifetime
- 2001-07-06 AT AT01947636T patent/ATE348886T1/de not_active IP Right Cessation
- 2001-07-06 AU AU2001269282A patent/AU2001269282A1/en not_active Abandoned
- 2001-07-06 WO PCT/GB2001/003034 patent/WO2002004638A1/en active IP Right Grant
- 2001-07-06 US US10/332,047 patent/US20040043432A1/en not_active Abandoned
-
2006
- 2006-06-28 US US11/427,112 patent/US20070031444A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60125364D1 (de) | 2007-02-01 |
EP1299537A1 (de) | 2003-04-09 |
US20070031444A1 (en) | 2007-02-08 |
US20040043432A1 (en) | 2004-03-04 |
GB0016811D0 (en) | 2000-08-30 |
AU2001269282A1 (en) | 2002-01-21 |
EP1299537B1 (de) | 2006-12-20 |
WO2002004638A1 (en) | 2002-01-17 |
CA2415478A1 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ333722A (en) | Soluble fatty acid derived peptide each with binding element more than 5kD as medicaments for disorders associated with inflammation or inappropriate complement activation | |
DK1328297T3 (da) | Funktionen af en haptoglobin-hæmoglobin receptor og anvendelser heraf | |
ATE359829T1 (de) | Wasserlösliche polymerkonjugate von retinoesäure | |
RS50966B (sr) | Agonisti pyy i njihova upotreba | |
DE69926647D1 (de) | Durch molekulares pathogenicid vermittelte krankheitsresistenz in pflanzen | |
WO2005053811A3 (en) | Biomolecule partition motifs and uses thereof | |
ATE485331T1 (de) | Thiolselektive wasserlösliche polymerderivate | |
ATE284242T1 (de) | Konnektor mit innerem verschiebeelement | |
AU2001282399A1 (en) | Resorcinol derivatives | |
WO2006077427A3 (en) | Antiviral drug combinations | |
SG171670A1 (en) | Rage fusion proteins, formulations, and methods of use thereof | |
DE502006006364D1 (de) | Copolymere auf basis von polyalkylenoxid-modifizierten n-vinyllactam-copolymeren | |
NO995978L (no) | Reseptorbindende konjugater | |
ATE348886T1 (de) | Auf zelluläre ziele gerichtete verbindungen | |
WO2007095286A3 (en) | AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS | |
ITMI20020189A1 (it) | Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli | |
AU6683900A (en) | Conjugate for mediating cell, compartment or membrane-specific transport of active substances | |
ATE253942T1 (de) | Bifunktionelle wasserlösliche polymer-derivate und diese enthaltende komplexe | |
WO2003089458A3 (en) | Conjugates of membrane translocating agents and pharmaceutically active agents | |
AU7303301A (en) | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof | |
YU90301A (sh) | Konjugati i postupci za njihovu proizvodnju i njihova upotreba za transport molekula kroz biološke membrane | |
DE502004005907D1 (de) | Selbstemulgierende wässrige polyurethandispersionen | |
NZ504240A (en) | Soluble CD8 molecule as an inhibitor of the cellular immune system | |
TW200722521A (en) | Novel bioconjugation reactions for acylating polyethylene glycol reagents | |
GB0220936D0 (en) | Modified therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |